Travere Therapeutics to Report Second Quarter 2026 Financial Results
Go back to Travere Therapeutics to Report Second Quarter 2026 Financial Results| (NASDAQ: TVTX) | Delayed: 65.91 -0.37 (0.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.28 | 52 Week High | $ | |||
| Open | $66.00 | 52 Week Low | $ | |||
| Day High | $66.60 | P/E | N/A | |||
| Day Low | $65.37 | EPS | $ | |||
| Volume | 244,094 | |||||

